ArticlePloS one2016

The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.

Kathrin Reiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.